Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Lubna N. Chaudhary MD

Lubna N. Chaudhary MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center

View Curriculum Vitae

Publications (29)

  • Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S) Explor Target Antitumor Ther 2023;4(6):1301-1309 PMID: 38213539 PMCID: PMC10776593 SCOPUS ID: 2-s2.0-85182367655 01/12/2024    
  • Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection. (Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN) WMJ 2023 Dec;122(5):418-421 PMID: 38180937 SCOPUS ID: 2-s2.0-85181850540 01/05/2024       1 Citation
  • Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature. (Gonzalez T, Nie Q, Chaudhary LN, Basel D, Reddi HV) Cancer Genet 2024 Apr;282-283:1-8 PMID: 38134587 SCOPUS ID: 2-s2.0-85180559446 12/22/2023    
  • National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS) Breast Cancer Res Treat 2024 Jan;203(2):317-328 PMID: 37864105 PMCID: PMC10872271 SCOPUS ID: 2-s2.0-85174540456 10/21/2023       2 Citations
  • Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Breast Cancer Res Treat 2023 Oct;201(3):387-396 PMID: 37460683 PMCID: PMC10795510 SCOPUS ID: 2-s2.0-85164922339 07/18/2023       2 Citations
  • Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy. (Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H) Res Sq 2023 Apr 07 PMID: 37066270 PMCID: PMC10104267 04/18/2023    
  • Worsening Rash in a Patient With Metastatic Breast Cancer. (Pierro MJ, Zhang AJ, Chaudhary LN) JAMA Oncol 2023 Apr 01;9(4):564-565 PMID: 36795394 SCOPUS ID: 2-s2.0-85153412803 02/17/2023    
  • High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. (Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H) JCO Precis Oncol 2023 Jan;7:e2100498 PMID: 36652667 PMCID: PMC9928763 01/19/2023    
  • Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation? (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S) Exploration of Targeted Anti-tumor Therapy 2023;4(6):1301-1309 SCOPUS ID: 2-s2.0-85182367655 01/01/2023    
  • Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. (Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC) J Cancer 2022;13(8):2472-2476 PMID: 35711833 PMCID: PMC9174868 SCOPUS ID: 2-s2.0-85130459904 06/18/2022       4 Citations
  • Sudden Paralysis in a 39-Year-Old Woman With Metastatic Breast Cancer. (Griffiths C, Connelly J, Chaudhary LN) JAMA Oncol 2021 Aug 01;7(8):1239-1240 PMID: 34042938 SCOPUS ID: 2-s2.0-85107333574 05/28/2021       1 Citation
  • Clinical and Psychosocial Challenges of Breast Cancer in Adolescent and Young Adult Women Under the Age of 40 Years. (Chaudhary LN) JCO Oncol Pract 2021 Jun;17(6):317-319 PMID: 33793341 PMCID: PMC8258001 SCOPUS ID: 2-s2.0-85108124069 04/02/2021       2 Citations
  • Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. (Kamaraju S, Fowler AM, Weil E, Wisinski KB, Truong TH, Lehr M, Chaudhary LN, Cheng YC, Chitambar CR, Rui H, Yee D, Lange C) Endocrinology 2021 Aug 01;162(8) PMID: 33735382 SCOPUS ID: 2-s2.0-85111784651 03/19/2021       7 Citations
  • Early stage triple negative breast cancer: Management and future directions (Chaudhary LN) Seminars in Oncology August 2020;47(4):201-208 SCOPUS ID: 2-s2.0-85085990383 08/01/2020       27 Citations
  • Early stage triple negative breast cancer: Management and future directions. (Chaudhary LN) Semin Oncol 2020 Aug;47(4):201-208 PMID: 32507668 PMCID: PMC7446736 SCOPUS ID: 2-s2.0-85085990383 06/09/2020       27 Citations
  • Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ? (Chaudhary LN, Jawa Z, Hanif A, Szabo A, Kamaraju S, Cheng YC, Chitambar CR) WMJ 2018 Jun;117(2):62-67 PMID: 30048574 SCOPUS ID: 2-s2.0-85051516380 07/27/2018       5 Citations
  • Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy? (Chaudhary LN, Wilkinson KH, Kong A) Surg Oncol Clin N Am 2018 Jan;27(1):141-153 PMID: 29132557 SCOPUS ID: 2-s2.0-85034238097 11/15/2017       105 Citations
  • Relevance of progesterone receptor immunohistochemical staining to Oncotype DX recurrence score. (Chaudhary LN, Jawa Z, Szabo A, Visotcky A, Chitambar CR) Hematol Oncol Stem Cell Ther 2016 Jun;9(2):48-54 PMID: 26808222 SCOPUS ID: 2-s2.0-84955577378 01/26/2016       36 Citations
  • Weight change associated with third-generation adjuvant chemotherapy in breast cancer patients. (Chaudhary LN, Wen S, Xiao J, Swisher AK, Kurian S, Abraham J) J Community Support Oncol 2014 Oct;12(10):355-60 PMID: 25853257 SCOPUS ID: 2-s2.0-84989201382 04/09/2015       13 Citations
  • Radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer. (Chaudhary LN, Knapp S, Wen S, Xiao J, Murano G, Kurian S, Layne G, Jacobson G, Abraham J) J Community Support Oncol 2015 Jan;13(1):27-9 PMID: 25839063 PMCID: PMC8375082 SCOPUS ID: 2-s2.0-84948450742 04/04/2015    
  • Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF. (Chaudhary L, Awan F, Cumpston A, Leadmon S, Watkins K, Tse W, Craig M, Hamadani M) J Clin Apher 2013 Oct;28(5):359-67 PMID: 23765597 SCOPUS ID: 2-s2.0-84885958621 06/15/2013       25 Citations
  • Unique association of myeloid neoplasm with eosinophilia and abnormalities of PDGFRA with TTP. (Chaudhary LN, Bailey NG, Vos JA, Stotler CJ) W V Med J 2013;109(2):6-9 PMID: 23600098 SCOPUS ID: 2-s2.0-84879425739 04/23/2013       2 Citations
  • Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era? (Chaudhary L, Kharfan-Dabaja MA, Hari P, Hamadani M) Bone Marrow Transplant 2013 Nov;48(12):1489-96 PMID: 23584438 SCOPUS ID: 2-s2.0-84889590282 04/16/2013       9 Citations
  • Nasal septum perforation induced by bevacizumab therapy in patients with breast cancer (Chaudhary L, Wilkinson R, Armeni M, Jordan C, Price A, Filburn S, Abraham J) Community Oncology August 2012;9(8):259-262 SCOPUS ID: 2-s2.0-84866428318 08/01/2012    
  • Perception of cancer recurrence risk: more information is better. (Kelly KM, Ajmera M, Bhattacharjee S, Vohra R, Hobbs G, Chaudhary L, Abraham J, Agnese D) Patient Educ Couns 2013 Mar;90(3):361-6 PMID: 22231022 SCOPUS ID: 2-s2.0-84873422146 01/11/2012       22 Citations
  • Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist? (Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A) J Oncol Pharm Pract 2007 Jun;13(2):69-75 PMID: 17873106 SCOPUS ID: 2-s2.0-34548623153 09/18/2007       24 Citations
  • Limitations of Sokal score in patients with chronic myeloid leukemia. (Hamadani SM, Chaudhary L) J Coll Physicians Surg Pak 2007 Mar;17(3):182; author reply 182 PMID: 17374310 SCOPUS ID: 2-s2.0-34548414552 03/22/2007    
  • McCune-Albright syndrome. (Hamadani M, Chaudhary L) Med J Aust 2006 Dec 4-18;185(11-12):597 PMID: 17181499 SCOPUS ID: 2-s2.0-33846109352 12/22/2006       1 Citation
  • Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy. (Hamadani M, Awab A, Chaudhary L, Tfayli A) J Oncol Pharm Pract 2006 Jun;12(2):67-8 PMID: 16984743 SCOPUS ID: 2-s2.0-34248191058 09/21/2006       3 Citations
    • Last update: 03/28/2024